0
Your cart

Your cart is empty

Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology

Buy Now

Biosimilars - Regulatory, Clinical, and Biopharmaceutical Development (Hardcover, 1st ed. 2018) Loot Price: R5,420
Discovery Miles 54 200
Biosimilars - Regulatory, Clinical, and Biopharmaceutical Development (Hardcover, 1st ed. 2018): Hiten J. Gutka, Harry Yang,...

Biosimilars - Regulatory, Clinical, and Biopharmaceutical Development (Hardcover, 1st ed. 2018)

Hiten J. Gutka, Harry Yang, Shefali Kakar

Series: AAPS Advances in the Pharmaceutical Sciences Series, 34

 (sign in to rate)
Loot Price R5,420 Discovery Miles 54 200 | Repayment Terms: R508 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the quality of the molecule, published information on the reference product, the current competitive environment, the target market and regulatory guidance, and most importantly, the emerging totality of evidence for the proposed biosimilar during development. For the ease of readers, the book comprises of six sections as follows: Section I: Business, Health Economics and Intellectual Property Landscape for Biosimilars Section II: Regulatory Aspects of Development and Approval for Biosimilars Section III: Biopharmaceutical Development and Manufacturing of Biosimilars Section IV: Analytical Similarity Considerations for Biosimilars Section V: Clinical aspects of Biosimilar Development Section VI: Biosimilars- Global Development and Clinical Experience Chapters have been written by one or more experts from academia, industry or regulatory agencies who have been involved with one or more aspects of biosimilar product development. The authors and editors have an expertise in commercialization and pricing of biosimilars, intellectual property considerations for biosimilars, chemistry manufacturing controls (CMC) and analytical development for biosimilars, regulatory and clinical aspects of biosimilar development. Besides the industry practitioners, the book includes several contributions from regulators across the globe.

General

Imprint: Springer International Publishing AG
Country of origin: Switzerland
Series: AAPS Advances in the Pharmaceutical Sciences Series, 34
Release date: December 2018
First published: 2018
Editors: Hiten J. Gutka • Harry Yang • Shefali Kakar
Dimensions: 235 x 155mm (L x W)
Format: Hardcover
Pages: 709
Edition: 1st ed. 2018
ISBN-13: 978-3-319-99679-0
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 3-319-99679-7
Barcode: 9783319996790

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners